UNSPSC 51284016: Rolitetracycline

This classification denotes a tetracycline antibiotic with the molecular formula C27H33N3O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GH9IW85221, chemically known as tetracycline, n-(pyrrolidinylmethyl)- but generally known as rolitetracycline, which bears US NIH Compound Identifier 5282179. European Medicines Agency schedules Rolitetracycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10368MIG.

UNSPSC 51284016 Rolitetracycline is a Commodity code nominally designating a specific tetracycline antibiotic, but recent state and local solicitations tagged with this code do not actually procure rolitetracycline itself. Instead, the code appears in opportunities for naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, emergency medical supplies, and generic pharmaceuticals — products and services entirely unrelated to the antibiotic's therapeutic scope. The mismatch between the code's nominal pharmaceutical product and the actual procurement activity suggests either systematic miscoding in state and local procurement systems or that the code has been repurposed outside its original taxonomy intent. State and local governments issuing under this code include county health departments (Seminole County, Florida), state HHS commissions and procurement offices (Texas HHS Commission, Minnesota Department of Administration), city purchasing and fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving multiple states including Oregon). The mix spans health and human services agencies, emergency response departments, and cooperative vehicles serving multiple jurisdictions.

Recent opportunities reflect pharmacy benefit program procurement and emergency medical supply acquisition across the South and Upper Midwest. Seminole County posted an IFB on June 30, 2026 (due July 26, 2026) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building and an estimated two-year term with renewal option. The City of Tampa issued an ITB (Bid 26-P-00145) on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, designated as a small local business enterprise sheltered market with a 5 percent bid discount. The Minnesota Department of Administration, through MMCAP, posted an RFP (S1070000015802) on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026. The Texas HHS Commission issued an RFI (HHS0017013) on April 3, 2026 (posted April 3, 2026) to explore direct-to-manufacturer prescription programs for self-insured health plans and state agencies. The code shows little relevant recent activity aligned with its nominal scope.